Henan Haitian Biotechnology Co Ltd

A GMP-certified veterinary drug manufacturer committed to long-term win-win partnership.

Henan Haitian Biotechnology Co Ltd
  • Home
  • About
  • Products
  • Contact
  • News
  • Home
  • About
  • Products
  • Contact
  • News
News

Feedlot chronic pens: what 52,886 cattle show

Chronic is not the same as condemned. Most cattle moved to feedlot chronic pens still reach market weight: 62 percent of 52,886 chronic animals tracked across 17 operations and seven years of records shipped at full weight. Respiratory disease led the diagnosis groups at a median 45.2 percent, lameness came second at 23.9 percent, and mortality took 23.1 percent. The spread between yards is wider than any of those figures.

Why feedlot chronic pens have been so poorly described

Beef production talks about animal welfare constantly. Industry policy books carry sections on cattle well-being, and the international animal health code has a chapter covering beef systems. The animals that actually test those commitments have been written about far less than the ones that stay healthy.

Earlier work described chronically impaired cattle as animals that stop responding to treatment, carry advanced or long-term illness or injury, or need extra help to get better. Acute cases work differently: those animals recover or die inside a shorter window. Nobody has settled on a standard definition, so the study behind these figures used an operational one: any animal that spent time in feedlot chronic pens.

Getting moved is not a coin flip. Under the shared protocols, crews weighed prior treatments for the same condition, general appearance, ability to compete in a home pen, and recovery time need. Chronic pens sit alongside hospital pens, where sick and injured animals get easier access to feed and water.

How the records were assembled and cleaned

The records came from a feedlot veterinary consulting and data-management service. Crews logged each animal event individually in chute-side software, working to standard protocols for arrival processing, treatments, rehandle events such as revaccination or reimplant, and postmortem findings, with yard data consolidated daily.

Extraction happened in stages, with arrival, treatment, and disposition records each checked before being merged. Entries were cross-referenced against yard reports, duplicates dropped, and missing values filled where possible. Once fields were recategorized and derived, 46 variables were left.

Three filtering steps produced the final set: lot-level records, then individual records for chronic animals in those lots, then removal of single event bullers, meaning animals treated once for being ridden and never treated again. Four yards had such animals at 10 percent or more of their chronic population. The reason was pen layout rather than health, since some yards kept a separate buller pen and others did not. Taking 15,759 of them out made the comparison fair.

Study design at a glance

ItemValue
Study typeRetrospective descriptive study
Data sourceA feedlot veterinary consulting and data-management service
Operations enrolled17 commercial feedlots across two major beef-producing regions
Enrollment thresholdAt least 7,000 head placed per year in every study year
Records periodSeven years, from 1 January 2014 through 31 December 2020
Lot-level sample11,956 lots representing 3,044,358 head
Chronic animals52,886 after exclusions
Excluded animals15,759 single event bullers
Variables retained46
Primary outcomesPredominant diagnosis group and final disposition

Chronicity and treatment rates across 17 operations

Chronicity ranged from 0.1 to 5 percent across yards, median 1.1 percent. A single large feedlot reported 1.3 percent for fall-placed calves years earlier, so the share that turns chronic looks stable.

Treatment rates for all conditions spanned 8.3 to 30.3 percent, median 17.7 percent, and respiratory treatment rates spanned 4.4 to 23.0 percent, median 10.4 percent. Neither figure counts each animal once. An animal treated in two diagnosis groups appears twice, so treat 17.7 percent as a ceiling on morbidity rather than a morbidity rate.

What the yards placed explains some of the spread. Median placement was 23,909 head per year, from 8,227 to 65,436, and average lot arrival weights ran 174 to 383 kg, median 303 kg. Calves were a median 69.1 percent of placements, from 11.8 to 100 percent, steers 67.3 percent from 46.1 to 100 percent, and beef-breed cattle 93.9 percent from 23.8 to 100 percent.

Lighter cattle get respiratory disease more often, so the yards taking the lightest arrivals should carry the most chronic animals. That did not hold cleanly. Both heaviest-arrival yards came in below average, while the two lightest-arrival yards went in opposite directions.

Respiratory disease and lameness: the two dominant diagnosis groups

Predominant diagnosis groupMedian share of chronic cattle (%)Range (%)
Respiratory45.219.1 to 99.1
Lameness23.90.1 to 50.5
Multiple8.80.5 to 15.7
Other5.10 to 18.4
Bullers2.70 to 24.3
Metabolic2.70 to 16.6
Musculoskeletal2.00 to 25.7

Bovine respiratory disease finishing first is expected, given that it is the main cause of sickness in beef feedlots, and earlier reports from other yards put the respiratory share at 49 percent, 35.7 percent and 57 percent.

Lameness is the one that breaks the pattern. At a median 23.9 percent it sits below the 48.5 percent, 37.4 percent and 33 percent reported elsewhere, and much of the gap is regional. Across operations in one of the two production regions, lameness made up 36.2 percent of chronic cattle, close to those earlier figures. In three operations in the other region, it missed the top three entirely.

The two groups were split apart on purpose. Lameness meant the feet, hoof, or joints. Musculoskeletal meant injury from facilities, equipment, or some other external cause. Different causes, different responses, so the split earns its place in the record.

Final dispositions: ship, rail and mortality

Final dispositionMedian share of chronic cattle (%)Range (%)Average days on feed
Ship at market weight62.020.1 to 94.1418
Rail before market weight9.40 to 49202
Mortality, all causes23.15.9 to 38.2134
Unassisted mortality18.65.7 to 37.5Not reported
Euthanasia mortality3.10 to 16Not reported

Shipping at market weight was the most common ending, and it was not close. Animals either went straight from the chronic pen or went back to a home pen to finish out. Shipped chronic cattle averaged 418 days on feed against 202 for railed animals, a gap of more than 200 days. Railing usually loses money on the animal, and so does carrying one that long.

Region showed up again. Six of nine operations in one region railed more than the median, while six of eight in the other region railed at or below it. Distance to a plant that accepts railers is a reasonable part of the answer.

The counterintuitive part: chronic does not mean culled

It is easy to picture a chronic pen as a place animals go to be written off. The numbers say otherwise.

Start with survival. A median 62 percent of chronic cattle got to market weight and shipped, which frames chronic status as a management problem more often than a death.

Then look at how the rest left. Among chronic cattle that died, a median 81.4 percent died unassisted and 18.6 percent were euthanized, with the euthanized share from 0 to 52 percent by yard. These animals get checked constantly, so the low euthanasia figure is a timing problem rather than a detection gap. Slow decline offers no clear day to act, and audit programs in both regions can fail a yard over it.

Then ask what the median is worth. Respiratory share ran 19.1 to 99.1 percent, lameness 0.1 to 50.5 percent, and rail rates 0 to 49 percent. No individual yard produced that number.

And lameness again. It rarely kills, which is exactly why it ties up pens. Space, labor, and days go to animals never really at risk.

Where flunixin meglumine and meloxicam fit in chronic pen care

The two biggest chronic diagnosis groups are also the two places where nonsteroidal anti-inflammatory drug (NSAID) therapy is routine in beef feedlots. Fever and inflammation in the lung on one side, pain in a foot, hoof, or joint on the other. Both push animals off feed, and an animal off feed is an animal off gain.

Flunixin meglumine and meloxicam get to the same place by different routes. Both inhibit cyclooxygenase and bring prostaglandin production down, which is what takes the fever off, settles inflammation, and dulls pain. Flunixin meglumine is a nicotinic acid derivative and meloxicam is an oxicam. Their kinetics differ, so the practical question is which one fits the interval a crew can hold to.

What gets underestimated is the repeat dosing. Animals that reach feedlot chronic pens have usually already had several rounds for the same condition, and more are coming. Volume sets a limit on what goes into one injection site, site tolerance sets a limit on how often the same muscle gets used, and withdrawal periods decide whether an animal that finally turns the corner can still be sold as a fed animal. In a pen whose whole job is getting cattle back to weight, none of that is a detail.

Patterns by year and season

Arrival seasonChronic cattle placed (head)
Fall17,309
Spring13,108
Winter12,002
Summer10,467

Chronic animals identified per year ran from 5,796 to 9,800, averaging 7,555 plus or minus 1,308 head. Fall arrivals produced the most, then spring, winter, and summer.

Diagnosis mix moved with season as well. Respiratory share stayed high in every season but ran about 14 percent higher among summer arrivals than winter or fall arrivals. Lameness ran about 1.75-fold higher in fall placements than summer placements, while buller share peaked in winter arrivals though buller events happened year round.

The source contradicts itself on the rail trend. The study summary says railed cattle increased across the study years. The discussion of yearly patterns says the proportion railed dropped five-fold. Only the respiratory increase of 1.7-fold gets stated both ways that agree, so the rail direction stays open here.

Practical decisions for chronic pen programs

  • Write the move criteria down. Prior treatments for one condition, general appearance, ability to compete in a home pen, and recovery time need are the four factors here.
  • Track railed animals apart from shipped ones. The median 9.4 percent rail rate hides the yards near 49 percent, and railing is where the money goes.
  • Keep lameness apart from musculoskeletal injury. Feet, hoof, and joint disorders point at one set of causes, facility injuries at another.
  • Read your own diagnosis mix before you compare it with anyone else. A respiratory share spanning 19.1 to 99.1 percent makes the median a question, not a target.
  • Build the analgesic protocol around repeat dosing in feedlot chronic pens. Injection volume, site rotation, and withdrawal intervals set the ceiling on courses per animal.
  • Put the euthanasia call into a written protocol with clear triggers.

Limitations of the reference values

These are descriptive reference values, not causal findings, and they serve best as feedlot benchmarks for comparable operations.

All 17 operations worked with the same veterinary consulting company. That brings consistency in training, diagnosis, and treatment protocols, and yard-to-yard variation still shows. It also means the values describing feedlot chronic pens come from a narrow slice of commercial production and should not be carried over to yards running different systems. The definition used here also differs from definitions elsewhere.

Diagnoses were assigned at each treatment event by trained yard personnel using standardized criteria, with oversight from consulting veterinarians, rather than by a veterinarian examining each animal. Grouping more than 30 specific diagnoses into seven categories lost detail, since conditions inside one category differ in cause and welfare effect.

The retrospective design ruled out anything absent from the records, including weather, pen conditions, and staffing changes. Moving decisions were made at yard level and varied despite shared training. Removing single event bullers likely understates that group’s size. Cattle prices held steady through most of the window, so this disposition mix may not reflect later markets.

Bottom line

Chronic pens are a small slice of the inventory and a large slice of the welfare exposure. Median chronicity was 1.1 percent, respiratory disease and lameness together covered roughly two thirds of chronic diagnoses, and 62 percent of these animals still got to market weight. The rest is where the work is: a median 9.4 percent railed early, and 23.1 percent dying with four fifths of those deaths unassisted. For any operation running feedlot chronic pens, the number worth watching is your own trend line by diagnosis and by disposition, not an industry average.

FAQ

What counts as a chronic animal in feedlot chronic pens

A chronic animal is any animal housed in the yard’s designated chronic pen at some point during the feeding period. This is an operational definition rather than a clinical one, chosen because no standard definition exists across the industry. Moves are decided at yard level using prior treatment count, general appearance, ability to compete in a home pen, and convalescence need.

How common are chronic cattle in a commercial feedlot

Chronicity rates across the 17 participating operations ranged from 0.1 to 5 percent, with a median of 1.1 percent. That median sits close to the 1.3 percent reported for fall-placed calves at a single large feedlot in an earlier study. Individual yards contributed as few as 51 chronic animals from 40 lots and as many as 21,468 from 879 lots.

Which diagnosis group fills most chronic pen spaces

Respiratory disease is the largest predominant diagnosis group, at a median 45.2 percent of chronic cattle and a range of 19.1 to 99.1 percent. Lameness is second at a median 23.9 percent of chronic cattle, with a range of 0.1 to 50.5 percent. Together the two groups account for roughly two thirds of chronic diagnoses across the yards studied.

Why is lameness such a large share of chronic pen populations

Lameness is rarely the primary cause of death, so affected animals stay in the pen for a long time rather than leaving through mortality. That makes it a large occupant of chronic pen space even where it is not the dominant killer. Rates also track pen conditions, climate, and weather, which vary sharply between production regions.

What share of chronic cattle still reach market weight

A median 62 percent of chronic cattle were shipped at market weight, with a range of 20.1 to 94.1 percent across the 17 operations studied here. These animals left either directly from the chronic pen or after returning to a home pen to finish out the feeding period. They averaged 418 days on feed against 202 days for railed chronic cattle, a gap of more than 200 days.

What does railing a chronic animal mean

Railing, sometimes called realizing, means shipping an animal for slaughter before it reaches optimal market weight. A median 9.4 percent of chronic cattle were railed, ranging from 0 to 49 percent, with an interquartile range of 6 to 14.9 percent. It usually reflects chronic condition, injury, or poor performance, and typically loses money.

How high is mortality among cattle in feedlot chronic pens

The median mortality rate among chronic cattle was 23.1 percent, ranging from 5.9 to 38.2 percent across the operations. Animals that died averaged 134 days on feed before death, and mortality was the most stable of the three dispositions. The total splits into a median 18.6 percent unassisted mortality and 3.1 percent euthanasia mortality.

Why is euthanasia such a small share of chronic pen deaths

Among chronic cattle that died, a median 81.4 percent died unassisted and only 18.6 percent were euthanized. That is surprising because animals in chronic pens are watched closely, where higher euthanasia rates would be expected. The likely reason is that slowly progressing conditions make timing hard, which is why written protocols matter.

Where do flunixin meglumine and meloxicam fit in chronic pen treatment

Both are nonsteroidal anti-inflammatory drugs used for analgesia and inflammation control in sick and lame cattle, the two largest chronic diagnosis groups. They inhibit cyclooxygenase and cut prostaglandin production, which lowers fever, reduces inflammation, and eases pain so animals keep eating. Flunixin meglumine is a nicotinic acid derivative while meloxicam is an oxicam.

How much do rates vary between feedlot chronic pens

Variation between individual operations was larger than any single summary figure. Chronicity ranged from 0.1 to 5 percent, respiratory diagnosis share from 19.1 to 99.1 percent, and lameness share from 0.1 to 50.5 percent. Rail rates ran from 0 to 49 percent with an interquartile range of 6 to 14.9 percent, and the yards above the median clustered by region.

beef feedlotbovine respiratory diseasebullerchronic cattlechronically impaired cattlechronicity ratecyclooxygenasedays on feeddescriptive reference valueseuthanasiafeedlot benchmarksfeedlot chronic pensfinal dispositionflunixin megluminehospital penhow common are chronic cattle in a commercial feedlothow high is mortality among cattle in feedlot chronic penshow much do rates vary between feedlot chronic pensinjection sitelamenessmeloxicammortality rateNSAIDpredominant diagnosis grouprailed cattlerespiratory diseasetreatment rateunassisted mortalitywhat counts as a chronic animal in feedlot chronic penswhat does railing a chronic animal meanwhat share of chronic cattle still reach market weightwhere do flunixin meglumine and meloxicam fit in chronic pen treatmentwhich diagnosis group fills most chronic pen spaceswhy is euthanasia such a small share of chronic pen deathswhy is lameness such a large share of chronic pen populationswithdrawal period

You May Also Like

FDA’s Approval of Faunamor: A Breakthrough for Ornamental Fish Health

April 11, 2025

The Hidden Risks of Using Raw Veterinary Drug Powders in Livestock Management

April 15, 2025

Why Measuring Butyrylcholinesterase Might Not Help in Organophosphorus Poisoning Treatment

March 26, 2026
2026 Henan Haitian Biotechnology Co., Ltd. ©.
Ashe Theme by WP Royal.